Brito, M.D., an endocrinologist associated with Division of Endocrinology, Diabetes, Metabolism and Nutrition at Mayo Clinic
4 min read GLP-1 Weight Loss Medication Coverage Is Changing What You Need to Know If you're taking a GLP-1 weight loss medication like Wegovy or Zepbound or thinking about starting one you may have heard that some insurance plans are changing their coverage
Novo Nordisk, a pharmaceutical company headquartered in Bagsvrd, Denmark, is primarily focused on developing treatments for diabetes, obesity and rare blood and endocrine disorders
Useful Links: Disclaimer: GLP-1 medications, including Mounjaro (Tirzepatide) and Semaglutide, require a medical evaluation and are not suitable for everyone
The medication may be taken long-term, provided it remains effective and is well tolerated